Matches in Nanopublications for { ?s ?p "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP857013.RAfnEUtE8_fLuPjmu7YGA0ylp6H7DJLXfbE1pVXJghQeA130_assertion description "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857013.RAfnEUtE8_fLuPjmu7YGA0ylp6H7DJLXfbE1pVXJghQeA130_provenance.
- NP649709.RAQ4b1nyZSPbucwlZvDhLPEuCtkC09Kl0MZkuD9bLBOMM130_assertion description "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649709.RAQ4b1nyZSPbucwlZvDhLPEuCtkC09Kl0MZkuD9bLBOMM130_provenance.
- NP649710.RAfY2KJCLuBHPF8OPu4k-2wWDD6nuF6UEQT9S7RVKuC3M130_assertion description "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649710.RAfY2KJCLuBHPF8OPu4k-2wWDD6nuF6UEQT9S7RVKuC3M130_provenance.
- NP649714.RABdHXVniAQ4fcPSYUn4WbsZd7hOcc5ME3NNpfgxD1XQo130_assertion description "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649714.RABdHXVniAQ4fcPSYUn4WbsZd7hOcc5ME3NNpfgxD1XQo130_provenance.
- NP677227.RAjlBJ2j6h0yxgnaXc70rSgCK8iXc_7NGUqdUF_hXuwwY130_assertion description "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP677227.RAjlBJ2j6h0yxgnaXc70rSgCK8iXc_7NGUqdUF_hXuwwY130_provenance.
- NP799479.RAp56Gp43xB3mbQ0RPUbo7SGMzf7ABJvBsoRo3yA6SmG4130_assertion description "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP799479.RAp56Gp43xB3mbQ0RPUbo7SGMzf7ABJvBsoRo3yA6SmG4130_provenance.
- NP649703.RAGL1YKJ1Q-9ZF1R6c7iykajUfP-dz9vtHE4T0lbWW49M130_assertion description "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649703.RAGL1YKJ1Q-9ZF1R6c7iykajUfP-dz9vtHE4T0lbWW49M130_provenance.
- NP674685.RA49ZqJGrLg2n61Dh6xuWUDlil2zQ1d4T6OitHLap5aVw130_assertion description "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674685.RA49ZqJGrLg2n61Dh6xuWUDlil2zQ1d4T6OitHLap5aVw130_provenance.
- NP767798.RA6GSGoL9ta-A_BZ3RdapgjeSsnFB2wFf0-9MIB3yqEFw130_assertion description "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767798.RA6GSGoL9ta-A_BZ3RdapgjeSsnFB2wFf0-9MIB3yqEFw130_provenance.
- NP679703.RA7q1bcdbCYcjpOi4C303-qKqRcCW8_cPY6h1YKtl59Qs130_assertion description "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679703.RA7q1bcdbCYcjpOi4C303-qKqRcCW8_cPY6h1YKtl59Qs130_provenance.
- NP649711.RA3WHme2rKDjyKyVYxp4POCNZ14ISj0w3BpNJIiXGOz6A130_assertion description "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649711.RA3WHme2rKDjyKyVYxp4POCNZ14ISj0w3BpNJIiXGOz6A130_provenance.
- NP649719.RA25AuYPH8_1cwElJeqCzasqkZz_tSjwk91JHODrdob-8130_assertion description "[In contrast to the pattern of p63 staining, the majority of the chondroblastomas (70%) demonstrated S-100 immunoreactivity while only a minority of the GCTOB (8%) was immunoreactive for S-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649719.RA25AuYPH8_1cwElJeqCzasqkZz_tSjwk91JHODrdob-8130_provenance.